Abstract
Lineage plasticity is a critical mechanism of therapeutic resistance in cancer. In a recent issue of Science, Chan and colleagues demonstrate that early lineage plasticity in prostate cancer is driven by JAK-STAT inflammatory cytokine signaling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have